I agree that this site is using cookies. You can find further informations here.
X
Park, Kwang‐Su
164  results:
Search for persons X
?
1

Newly developed oral bioavailable EHMT2 inhibitor as a pote..:

Wang, Sung Eun ; Xiong, Yan ; Jang, Mi-Ae...
Molecular Therapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Discovery of a novel, highly potent EZH2 PROTAC degrader fo..:

Velez, Julia ; Dale, Brandon ; Park, Kwang-Su...
European Journal of Medicinal Chemistry.  267 (2024)  - p. 116154 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Discovery of the First-in-Class G9a/GLP PROTAC Degrader:

Velez, Julia ; Han, Yulin ; Yim, Hyerin...
Journal of Medicinal Chemistry.  67 (2024)  8 - p. 6397-6409 , 2024
Link: https://doi.org/10.1021/..
 
?
4

Discovery and Characterization of a Novel Cereblon-Recruiti..:

Kabir, Md ; Qin, Lihuai ; Luo, Kaixiu...
Journal of Medicinal Chemistry.  67 (2024)  8 - p. 6880-6892 , 2024
Link: https://doi.org/10.1021/..
 
?
5

Discovery of a Potent, Selective, and Cell-Active SPIN1 Inh..:

Xiong, Yan ; Greschik, Holger ; Johansson, Catrine...
Journal of Medicinal Chemistry.  67 (2024)  7 - p. 5837-5853 , 2024
Link: https://doi.org/10.1021/..
 
?
6

Targeted Degradation of PRC1 Components, BMI1 and RING1B, v..:

Park, Kwang‐Su ; Qin, Lihuai ; Kabir, Md...
Advanced Science.  10 (2023)  10 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
7

Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degr..:

Xiong, Yan ; Zhong, Yue ; Yim, Hyerin...
Journal of the American Chemical Society.  144 (2022)  49 - p. 22622-22632 , 2022
Link: https://doi.org/10.1021/..
 
?
8

Assessment of organochlorine pesticides in the atmosphere o..:

Lee, Myungsup ; Lee, Sumin ; Noh, Seam...
Environmental Monitoring and Assessment.  194 (2022)  10 - p. , 2022
Link: https://doi.org/10.1007/..
 
?
9

Discovery of Potent, Selective, and In Vivo Efficacious AKT..:

Yu, Xufen ; Xu, Jia ; Shen, Yudao...
Journal of Medicinal Chemistry.  65 (2022)  4 - p. 3644-3666 , 2022
Link: https://doi.org/10.1021/..
 
?
10

Targeting Triple-Negative Breast Cancer by a Novel Proteoly..:

Dale, Brandon ; Anderson, Chris ; Park, Kwang-Su...
ACS Pharmacology & Translational Science.  5 (2022)  7 - p. 491-507 , 2022
Link: https://doi.org/10.1021/..
 
?
11

EZH2 noncanonically binds cMyc and p300 through a cryptic t..:

Wang, Jun ; Yu, Xufen ; Gong, Weida...
Nature Cell Biology.  24 (2022)  3 - p. 384-399 , 2022
Link: https://doi.org/10.1038/..
 
?
12

Discovery of a First-in-Class Degrader for Nuclear Receptor..:

Meng, Fanye ; Xu, Chenxi ; Park, Kwang-Su...
Journal of Medicinal Chemistry.  65 (2022)  15 - p. 10611-10625 , 2022
Link: https://doi.org/10.1021/..
 
?
13

A cryptic transactivation domain of EZH2 binds AR and AR's ..:

Wang, Jun ; Park, Kwang-Su ; Yu, Xufen...
Nucleic Acids Research.  50 (2022)  19 - p. 10929-10946 , 2022
Link: https://doi.org/10.1093/..
 
?
14

Discovery of the First-in-Class G9a/GLP Covalent Inhibitors:

Park, Kwang-Su ; Xiong, Yan ; Yim, Hyerin...
Journal of Medicinal Chemistry.  65 (2022)  15 - p. 10506-10522 , 2022
Link: https://doi.org/10.1021/..
 
?
15

A First-in-Class, Highly Selective and Cell-Active Alloster..:

Shen, Yudao ; Li, Fengling ; Szewczyk, Magdalena M....
Journal of Medicinal Chemistry.  64 (2021)  7 - p. 3697-3706 , 2021
Link: https://doi.org/10.1021/..
 
1-15